| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 99 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 84 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 82 | 2024 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 55 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 53 | 2024 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 36 | 2023 |
| Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 M Safdarian, E Trinka, V Rahimi-Movaghar, A Thomschewski, A Aali, ... The Lancet Neurology 22 (11), 1026-1047, 2023 | 35 | 2023 |
| Clinical implications of difference in antigenicity of different botulinum neurotoxin type A preparations: clinical take-home messages from our research pool and literature S Samadzadeh, B Ürer, R Brauns, D Rosenthal, JI Lee, P Albrecht, ... Toxins 12 (8), 499, 2020 | 26 | 2020 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 21 | 2024 |
| Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran R Abolfazli, S Samadzadeh, T Sabokbar, B Siroos, SA Armaki, ... Journal of the neurological sciences 345 (1-2), 92-96, 2014 | 21 | 2014 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 GBDI Collaborators EClinicalMedicine, 2023 | 20 | 2023 |
| The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease … GBDCACD Collaborators The Lancet 402 (10398), 313-335, 2023 | 16 | 2023 |
| Long‐term adherence and response to botulinum toxin in different indications JI Lee, A Jansen, S Samadzadeh, U Kahlen, M Moll, M Ringelstein, ... Annals of Clinical and Translational Neurology 8 (1), 15-28, 2021 | 14 | 2021 |
| Disease progression of idiopathic cervical dystonia in spite of improvement after botulinum toxin therapy H Hefter, I Schomaecker, M Schomaecker, S Samadzadeh Frontiers in Neurology 11, 588395, 2020 | 14 | 2020 |
| Omalizumab prevents anaphylactoid reactions to mRNA COVID‐19 vaccine A Smola, S Samadzadeh, L Müller, O Adams, B Homey, P Albrecht, ... Journal of the European Academy of Dermatology and Venereology 35 (11), e743, 2021 | 13 | 2021 |
| Clinical improvement after treatment with incobotulinumtoxinA (XEOMIN®) in patients with cervical dystonia resistant to botulinum toxin preparations containing complexing proteins H Hefter, CJ Hartmann, U Kahlen, S Samadzadeh, D Rosenthal, M Moll Frontiers in Neurology 12, 636590, 2021 | 13 | 2021 |
| Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 JR Ledesma, J Ma, M Zhang, AVL Basting, HT Chu, A Vongpradith, ... The Lancet Infectious Diseases, 2024 | 11 | 2024 |
| Significantly lower antigenicity of incobotulinumtoxin than abo-or onabotulinumtoxin H Hefter, D Rosenthal, A Jansen, R Brauns, B Ürer, H Bigalke, ... Journal of Neurology 270 (2), 788-796, 2023 | 10 | 2023 |
| The impact of SARS-CoV-2 pandemic lockdown on a botulinum toxin outpatient clinic in Germany S Samadzadeh, R Brauns, D Rosenthal, H Hefter Toxins 13 (2), 101, 2021 | 10 | 2021 |
| HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients S Samadzadeh, E Tabibian, T Sabokbar, A Shakoori, SR Dehgolan, ... Journal of the Neurological Sciences 352 (1-2), 37-40, 2015 | 10 | 2015 |
Philipp AlbrechtProfessor of Neurology在 mariahilf.de 的电子邮件经过验证
Philipp AlbrechtProfessor of Neurology在 mariahilf.de 的电子邮件经过验证
Alfons SchnitzlerProfessor and Chairman, Heinrich-Heine-University Düssseldorf在 med.uni-duesseldorf.de 的电子邮件经过验证